Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

10.09 +0.08 (+0.75%)

Streaming Delayed Price Updated: 1:55 PM EST, Nov 17, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	588,026
Open	10.00
Bid (Size)	10.02 (700)
Ask (Size)	10.15 (100)
Prev. Close	10.01
Today's Range	9.685 - 10.25
52wk Range	2.622 - 65.80
Shares Outstanding	66,956,800
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 13, 2025

From Vor Biopharma

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Performance

YTD	-55.0%	-55.0%
1 Month	-65.2%	-65.2%
3 Month	-75.3%	-75.3%
6 Month	+187.3%	+187.3%
1 Year	-35.5%	-35.5%

More News

Let's take a look at the stocks that are in motion in today's session. ↗

November 11, 2025

Via Chartmill

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗

November 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 11, 2025

Via Chartmill

Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial ↗

November 11, 2025

Via Benzinga

US Stocks Mixed; Sea Shares Gain After Q3 Results ↗

November 11, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

November 11, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 11, 2025

Via Benzinga

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

November 10, 2025

From Vor Biopharma

Via GlobeNewswire

These stocks are moving in today's after hours session ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock

November 10, 2025

From Vor Biopharma

Via GlobeNewswire

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

November 08, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio to Participate in Upcoming Investor Conferences

November 07, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer

November 03, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 31, 2025

From Vor Biopharma

Via GlobeNewswire

Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data

October 29, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease

October 22, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025

October 17, 2025

From Vor Biopharma

Via GlobeNewswire

Novartis Strengthens Kidney Disease Pipeline With Promising Data ↗

October 16, 2025

Via Benzinga

Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine

October 16, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears ↗

October 14, 2025

Via Benzinga

Frequently Asked Questions

Is Vor Biopharma Inc. - Common Stock publicly traded?

Yes, Vor Biopharma Inc. - Common Stock is publicly traded.

What exchange does Vor Biopharma Inc. - Common Stock trade on?

Vor Biopharma Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Vor Biopharma Inc. - Common Stock?

The ticker symbol for Vor Biopharma Inc. - Common Stock is VOR on the Nasdaq Stock Market

What is the current price of Vor Biopharma Inc. - Common Stock?

The current price of Vor Biopharma Inc. - Common Stock is 10.09

When was Vor Biopharma Inc. - Common Stock last traded?

The last trade of Vor Biopharma Inc. - Common Stock was at 11/17/25 01:55 PM ET

What is the market capitalization of Vor Biopharma Inc. - Common Stock?

The market capitalization of Vor Biopharma Inc. - Common Stock is 675.26M

How many shares of Vor Biopharma Inc. - Common Stock are outstanding?

Vor Biopharma Inc. - Common Stock has 675M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.